Discover why some women develop fibroids while others don't, from genetics and hormones to lifestyle and environmental ...

Fibroids are non-cancerous smooth muscle tumors ... Now more than ever, your support is critical to help us keep our community informed about the evolving coronavirus pandemic and the impact ...

The sudden shutdown of millions of dollars in federal funding to Columbia University this month is already disrupting medical ...

University appoints new official to review Middle East programs Has recruited special officers with power to make campus ...

Columbia University agreed to some changes demanded by US President Donald Trump's administration before it can negotiate to ...

The shutdown of federal funding has disrupted medical and scientific research at the school. Read more at straitstimes.com.

Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of therapy.

It is thought that around five million women in the US have uterine fibroids that cause symptoms, with two-thirds of them inadequately treated with current drugs – generally off-label oral ...

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday.

Thousands of women sue after two studies, that followed a combined 78,000 women, showed an association between hair relaxer use and cancer.